Trial Profile
A randomized placebo-controlled trial to evaluate the effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Renal failure; Renal impairment
- Focus Therapeutic Use
- 01 Dec 2015 New trial record